Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients.

Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients.

Item
http://www.wikidata.org/entity/Q40831660
Towards Stratified Medicine in Plasma Cell MyelomaSerum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients.Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma.Immunoparesis defined by heavy+light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosis.The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.The clinical utility of serum free light chain and heavy/light chain assays in monitoring disease activity in patients with IgG myeloma after achieving a deep response.Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients.
P2860

Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients.

Item
http://www.wikidata.org/entity/Q40831660
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Levels of uninvolved immunoglo ...... for multiple myeloma patients.
@en
type
label
Levels of uninvolved immunoglo ...... for multiple myeloma patients.
@en
prefLabel
Levels of uninvolved immunoglo ...... for multiple myeloma patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Levels of uninvolved immunoglo ...... for multiple myeloma patients.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698